Who invested in Ascletis?
Ascletis's investors include Goldman Sachs, C-Bridge Capital, Pavillion Capital, Tasly Pharmaceutical and Hangzhou Binjiang Investment Holding.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$255Mraised across 4 rounds since 2011, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ascletis's investors include Goldman Sachs, C-Bridge Capital, Pavillion Capital, Tasly Pharmaceutical and Hangzhou Binjiang Investment Holding.
Ascletis has raised $255M across 4 rounds since 2011.
Ascletis's most recent round was a Series B of $100M in Jan 2017.
Its most recent round, $100M in Jan 2017, is also its largest on record.
Ascletis's first round on record, in Apr 2011, was backed by Hangzhou Binjiang Investment Holding.
Ascletis's latest named round is a Series B, in Jan 2017.
Ascletis is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.